{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:12:59Z","timestamp":1792203179153,"version":"4.4.0"},"reference-count":19,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,15]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultrarare disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and ischemic organ damage caused by pathogenic ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) variants. ADAMTS13-containing product, including fresh-frozen plasma (FFP), and plasma-derived factor VIII concentrates are commonly used to supply ADAMTS13; however, frequent hospital visits and allergic reactions are major drawbacks. A recombinant ADAMTS13 (rADAMTS13) was recently developed to address these issues. However, real-world evidence has not been reported owing to the rarity of this condition. This study compared the efficacy and safety of FFP and rADAMTS13 in 14 Japanese patients, including 5 patients with end-stage renal disease who were excluded from the phase 3 trial. The median peak level of ADAMTS13 activity 15 minutes after rADAMTS13 administration was significantly higher than that after FFP (68.4% vs 15.9%; P\u00a0&amp;lt; .001). ADAMTS13 activity 1 week after rADAMTS13 administration was well maintained compared with FFP infusion (11.6% vs 5.1%; P\u00a0&amp;lt; .001). Patients reported no allergic reactions after rADAMTS13 administration and appreciated the convenience of a single infusion of rADAMTS13, suggesting that rADAMTS13 is a safe and effective alternative to FFP in patients with cTTP. To our knowledge, this is the first publication of patients with cTTP who switched FFP to novel rADAMTS13 from Japanese real-world data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024027516","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T20:54:56Z","timestamp":1742158496000},"page":"2390-2395","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data"],"prefix":"10.1182","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-7931","authenticated-orcid":false,"given":"Kazuya","family":"Sakai","sequence":"first","affiliation":[{"name":"1Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hamamura","sequence":"additional","affiliation":[{"name":"1Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Higashiosaka City Medical Center, Higashiosaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Abe","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Oita Koseiren Tsurumi Hospital, Beppu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9766-0157","authenticated-orcid":false,"given":"Kazuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"5Department of Nephrology, Aichi Children's Health and Medical Center, Obu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-7074","authenticated-orcid":false,"given":"Norimichi","family":"Hattori","sequence":"additional","affiliation":[{"name":"6Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazuko","family":"Tokugawa","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kanai","sequence":"additional","affiliation":[{"name":"8Department of Pediatrics, Shimane Prefectural Central Hospital, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Ikejiri","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Okuizumo Town Hospital, Okuizumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-9815","authenticated-orcid":false,"given":"Masahiro","family":"Takeyama","sequence":"additional","affiliation":[{"name":"10Division of Hemophilia, National Hospital Organization, Osaka National Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhisa","family":"Taoka","sequence":"additional","affiliation":[{"name":"11Department of Hematology, Sakaide City Hospital, Sakaide, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fujita","sequence":"additional","affiliation":[{"name":"12Department of Diabetes\/Endocrinology\/Hematology, Saiseikai Yamaguchi General Hospital, Yamaguchi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-8657","authenticated-orcid":false,"given":"Minoru","family":"Kanaya","sequence":"additional","affiliation":[{"name":"13Blood Disorders Center, Aiiku Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[{"name":"14Department of Hematology\/Oncology, Saitama Children's Medical Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9127-997X","authenticated-orcid":false,"given":"Hiroshi","family":"Shiragami","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Izumiotsu Medical Center, Izumi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Azumi","sequence":"additional","affiliation":[{"name":"1Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-8943","authenticated-orcid":false,"given":"Kenki","family":"Saito","sequence":"additional","affiliation":[{"name":"1Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-3126","authenticated-orcid":false,"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"1Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan"},{"name":"16Department of Hematology, Nara Medical University, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2025051511211591800_bib1","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMra1813013","article-title":"Hereditary thrombotic thrombocytopenic purpura","volume":"381","author":"Kremer Hovinga","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2025051511211591800_bib2","first-page":"3365","article-title":"Clinical manifestations, current and future therapy, and long-term outcomes in congenital thrombotic thrombocytopenic purpura","volume":"12","author":"Sakai","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"10","key":"2025051511211591800_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"2025051511211591800_bib4","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2025051511211591800_bib5","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"issue":"22","key":"2025051511211591800_bib6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"2025051511211591800_bib7","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2019000601","article-title":"Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome","volume":"3","author":"Fujimura","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"2025051511211591800_bib8","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/jth.15064","article-title":"Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura","volume":"18","author":"Sakai","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2025051511211591800_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH13-08-0713","article-title":"The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications","volume":"111","author":"von Krogh","year":"2014","journal-title":"Thromb Haemost"},{"issue":"25","key":"2025051511211591800_bib10","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood.2020009801","article-title":"Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura","volume":"137","author":"Tarasco","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2025051511211591800_bib11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2001.03222.x","article-title":"Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress","volume":"115","author":"Yagi","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"2025051511211591800_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2006.06264.x","article-title":"The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura","volume":"135","author":"Scully","year":"2006","journal-title":"Br J Haematol"},{"issue":"7","key":"2025051511211591800_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MPH.0b013e3182755c38","article-title":"Successful treatment of congenital TTP with a novel approach using plasma-derived factor VIII","volume":"35","author":"Naik","year":"2013","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"5","key":"2025051511211591800_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12185-023-03657-0","article-title":"Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023","volume":"118","author":"Matsumoto","year":"2023","journal-title":"Int J Hematol"},{"issue":"10","key":"2025051511211591800_bib15","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/jth.15009","article-title":"Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"19","key":"2025051511211591800_bib16","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"},{"issue":"17","key":"2025051511211591800_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJMoa2314793","article-title":"Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura","volume":"390","author":"Scully","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"2025051511211591800_bib18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"issue":"3","key":"2025051511211591800_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/20\/2390\/2374656\/blood_bld-2024-027516-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/20\/2390\/2374656\/blood_bld-2024-027516-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T15:21:27Z","timestamp":1747322487000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/20\/2390\/536089\/Therapeutic-switch-from-plasma-to-recombinant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":19,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027516","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}